GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 11/28/2012 9:27:41 PM : Outperform Start Price: $3.99 GTXI Score: +8.55

may get some external help in promoting the price UP here

Featured Broker Partners


Advertisement